Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant

被引:60
作者
Mohamed, AN
Palutke, M
Eisenberg, L
Al-Katib, A
机构
[1] Dept Pathol, Detroit, MI 48201 USA
[2] Cytogenet Lab, Detroit, MI 48201 USA
[3] Wayne State Univ, Dept Internal Med, Detroit, MI 48201 USA
关键词
D O I
10.1016/S0165-4608(00)00383-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have identified 52 patients of follicular lymphoma (FL) with t(14;18)(q32;q21). Histologically, the lymphomas were placed into six groups according to their cellular composition and growth pattern. Chromosome analysis revealed that all cases but one had additional secondary chromosomal abnormalities. The most frequent numerical aberrations were gains of chromosomes 7 (38%), X (36%), 5 (15%), 12 (15%), 18/der(18)t(14;18) (25%), and 21 (15%). Structural abnormalities of chromosome 1 were seen in 19 tumors (36%) affecting both arms with breakpoints clustered at 1p36. Other structural abnormalities included partial deletions of 6q, 10q, and 13q. Breakpoint at 8q24 was seen in four cases. The chromosome aberrations were correlated with the morphological subtypes of follicular lymphoma. Gain of chromosome 7 appeared to be associated with follicular large cell lymphoma. The incidence of trisomy 5 and 12, and 13q- was higher in follicular lymphoma with aggressive histological features than in low-grade lymphoma. In addition, complexity of the karyotype and high degree of polyploidy increased with the grade. The most valuable cytogenetic markers in the t(14;18) lymphomas are those involving 8q24 which was found exclusively in the blastic/blastoid variant FL. Therefore, chromosome analysis in relation to histologic pattern of follicular lymphoma can provide additional information in predicting tumor evolution and transformation to a higher-grade malignancy. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 28 条
[1]   CORRELATION OF SECONDARY CYTOGENETIC ABNORMALITIES WITH HISTOLOGIC APPEARANCE IN NON-HODGKINS LYMPHOMAS BEARING T(14, 18)(Q32, Q21) [J].
ARMITAGE, JO ;
SANGER, WG ;
WEISENBURGER, DD ;
HARRINGTON, DS ;
LINDER, J ;
BIERMAN, PJ ;
VOSE, JM ;
PURTILO, DT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (08) :576-580
[2]  
BAKSHI A, 1985, CELL, V41, P899
[3]   High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma [J].
Bentz, M ;
Werner, CA ;
Dohner, H ;
Joos, S ;
Barth, TFE ;
Siebert, R ;
Schroder, M ;
Stilgenbauer, S ;
Fischer, K ;
Moller, P ;
Lichter, P .
BLOOD, 1996, 88 (04) :1437-1444
[4]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
[5]   TRANSLOCATION (14-18) AND (8-22) IN 3 PATIENTS WITH ACUTE-LEUKEMIA LYMPHOMA FOLLOWING CENTROCYTIC CENTROBLASTIC NON-HODGKINS-LYMPHOMA [J].
FIEDLER, W ;
WEH, HJ ;
ZELLER, W ;
FONATSCH, C ;
HILLION, J ;
LARSEN, C ;
WORMANN, B ;
HOSSFELD, DK .
ANNALS OF HEMATOLOGY, 1991, 63 (05) :282-287
[6]   The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
MODERN PATHOLOGY, 2000, 13 (02) :193-207
[7]  
Heim S., 2015, CANC CYTOGENETICS
[8]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[9]  
HUBBARD SM, 1982, BLOOD, V59, P258
[10]  
JOHANSSON B, 1994, LEUKEMIA, V8, P953